As the latter often contain regulatory elements, we interrogated EnhancerAtlas 2.0 (Gao & Qian, 2020) and found enrichment for enhancers with known activity in CD34+, AML blasts, and CD8+ T‐cells among the GPR56high‐specific peaks, whereas enhancers associated with monocytes and macrophages were significantly enriched in the GPR56low group (Fig 1C). This evidence concerns the gene CD8A and acute myeloid leukemia.